Board Meeting15 May 2026, 02:16 pm
MPS Ltd Board Approves FY26 Audited Financial Results
AI Summary
The Board of Directors of MPS Ltd approved the audited financial results for the fourth quarter (Q4) and financial year ended 31 March 2026. Walker Chandiok & Co LLP issued an unmodified opinion on the results. The board decided not to recommend a final dividend for FY 2025-26. KPMG Assurance and Consulting Services LLP was appointed as the Internal Auditors for three years starting FY 2026-27. Walker Chandiok & Co LLP was re-appointed as Statutory Auditors for a second term of five years, subject to shareholder approval.
Key Highlights
- Audited financial results for Q4 and FY26 approved with unmodified opinion from Walker Chandiok & Co LLP.
- No final dividend recommended for FY 2025-26 due to capital deployment in Unbound Medicine acquisition.
- KPMG appointed as Internal Auditors for three years starting FY 2026-27.
- Walker Chandiok & Co LLP re-appointed as Statutory Auditors for five years, subject to shareholder approval.
Price Impact
More from MPSLTD